Financially Strong Stocks Under ₹150 to Look Out For

Synopsis: Stocks priced below Rs. 150 can still offer strong fundamentals, with several companies delivering healthy returns on capital, low debt levels, attractive valuations, and consistent profit growth over the years.

Affordable stock prices do not necessarily indicate weak businesses. Several companies trading below Rs. 150 have built strong financial foundations, supported by healthy profitability, efficient capital allocation, disciplined balance sheets, and consistent earnings growth.

Metrics such as ROCE, ROE, debt-to-equity ratio, valuation multiples, and long-term profit growth provide valuable insights into a company’s financial quality. Here are five stocks priced below Rs. 150 that stand out for their strong fundamentals and financial performance.

Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd is an Indian pharmaceutical company engaged in the manufacturing and marketing of a wide range of generic medicines, including tablets, capsules, injectables, syrups, and ointments. The company serves both domestic and international markets, with a strong presence in exports across Asia, Africa, Latin America, and CIS countries. With a market capitalisation of Rs. 1,329 cr, the shares of Syncom Formulations (India) Ltd closed at Rs. 14.14 per share, up from its previous close of Rs. 14.01 per share.

The company demonstrates strong financial health with an ROCE of 26.8% and ROE of 20.2%, while remaining debt-free with a debt-to-equity ratio of 0.00. It appears attractively valued, trading at a P/E of 16.9 versus the industry P/E of 35.0, with a PEG ratio of 0.30. Additionally, the company has delivered impressive compounded profit growth of 22% over 10 years, 21% over 5 years, and 56% over the last 3 years.

Premier Polyfilm Ltd

Premier Polyfilm Ltd manufactures flexible PVC products used across sectors such as healthcare, automotive, infrastructure, and consumer goods. Its product portfolio includes PVC films, sheets, artificial leather cloth, and flooring materials. The company caters to both domestic and export markets, supplying customized polymer-based solutions to industrial customers. With a market capitalisation of Rs. 665 cr, the shares of Premier Polyfilm Ltd closed at Rs. 63.51 per share, down from its previous close of Rs. 63.61 per share.

The company showcases robust financial strength with an ROCE of 30.8% and ROE of 24.0%, while maintaining a debt-free balance sheet with a debt-to-equity ratio of 0.00. It also has an attractive PEG ratio of 0.50, indicating reasonable valuation relative to growth. Additionally, the company has delivered strong compounded profit growth of 24% over 10 years, 31% over 5 years, and 40% over the last 3 years.

String Metaverse Ltd

String Metaverse Ltd is a technology-focused company offering IT services, software development, digital transformation, cloud solutions, and emerging technology applications. The company is expanding its presence in areas such as artificial intelligence, blockchain, Web3, and metaverse-related solutions, while serving clients across multiple industries with customized digital services. With a market capitalisation of Rs. 811 cr, the shares of String Metaverse Ltd closed at Rs. 6.65 per share, down from its previous close of Rs. 6.69 per share. 

The company stands out with exceptional profitability, reporting an ROCE and ROE of 41.6% each, while maintaining a near debt-free balance sheet with a debt-to-equity ratio of 0.02. It also appears attractively valued, trading at a P/E of 8.04, significantly below the industry average P/E of 23.0, with a remarkably low PEG ratio of 0.02, indicating strong growth potential relative to its valuation.

Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd is engaged in the manufacturing and trading of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company markets a range of healthcare products across therapeutic segments and also exports medicines to international markets. With a market capitalisation of Rs. 1,508 cr, the shares of Shukra Pharmaceuticals Ltd closed at Rs. 34.45 per share, down from its previous close of Rs. 34.46 per share.

The company exhibits strong financial performance with an ROCE of 36.9% and ROE of 28.9%, supported by a low debt-to-equity ratio of 0.06. It also has a PEG ratio of 0.94, indicating a reasonable valuation relative to its growth prospects. Additionally, the company has delivered exceptional compounded profit growth of 53% over 10 years, 175% over 5 years, and 71% over the last 3 years. 

Radhika Jeweltech Ltd

Radhika Jeweltech Ltd is a jewellery manufacturer and retailer specializing in gold, diamond, silver, platinum, and gemstone jewellery. The company offers a wide range of traditional and contemporary designs through its retail showrooms and caters to bridal, festive, and everyday jewellery demand. With a market capitalisation of Rs. 733 cr, the shares of Radhika Jeweltech Ltd closed at Rs. 62.16 per share, down from its previous close of Rs. 63.55 per share.

The company maintains solid financial fundamentals with an ROCE of 25.1% and ROE of 20.8%, while keeping a low debt-to-equity ratio of 0.15. It appears attractively valued, trading at a P/E of 8.87, well below the industry average P/E of 17.9, with a PEG ratio of 0.25. Additionally, the company has delivered strong compounded profit growth of 38% over 10 years, 27% over 5 years, and 36% over the last 3 years.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Financially Strong Stocks Under ₹150 to Look Out For appeared first on Trade Brains.